C4 therapeutics to present at the 42nd annual j.p. morgan healthcare conference

Watertown, mass., jan. 04, 2024 (globe newswire) -- c4 therapeutics, inc. (c4t) (nasdaq: cccc), a clinical-stage biopharmaceutical company dedicated to advancing targeted protein degradation science to develop a new generation of small-molecule medicines and transform how disease is treated, today announced that the company will present at the upcoming 42nd annual j.p. morgan healthcare conference taking place in san francisco on thursday, january 11 at 9:00 am pst (12:00 pm est).
CCCC Ratings Summary
CCCC Quant Ranking